Award recordCONTRACT

WALGREEN CO.

PIID 36C24518P2344· VHA· 245-NETWORK CONTRACT OFFICE 5 (36C245)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $76,548 net obligations· UEI HRE3UMLEM2P5· IL

Description

LEMTRADA IV INJECTIONS

First action · last action
2018-03-06 · 2018-03-06
Transactions
1
First transaction's obligation
$76,548
Base + all options value (sum of deltas)
$76,548
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$76,548$0Base award · 2018-03-06 · this action $76,548 · running total $76,548
  • Base2018-03-06+$76,548= $76,548
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-03-06+$76,548$76,548LEMTRADA IV INJECTIONS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI HRE3UMLEM2P5)

AwardOffice · PSC / listingNet obligationsFY
36C24922P0128249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$18,520FY2022
36C24922P0070249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$18,520FY2022
36C79119N0016STRATEGIC ACQUISITION CENTER FREDERICKSBURG (36C10G) · Q517 · MEDICAL- PHARMACOLOGY$3,253,600FY2019
36C79119D0032COMMODITIES & SERVICES ACQUISITION SERVICE (36C791) · Q517 · MEDICAL- PHARMACOLOGY$0FY2019
36C24519P0773245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$94,972FY2019
36C24519P0425245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$47,486FY2019

Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24526N0840TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$19,139FY2026
36C24526N0839TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$38,360FY2026
36C24526N0837QOL MEDICAL LLC245-NETWORK CONTRACT OFFICE 5 (36C245)$16,945FY2026
36C24526N0835TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$34,605FY2026
36C24526N0834GALDERMA LABORATORIES, L.P.245-NETWORK CONTRACT OFFICE 5 (36C245)$16,960FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24518P2344_3600_-NONE-_-NONE- · retrieved 2026-09-26.